Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: a multi-regional health economic analysis

RM Rogoza, N Ferko, J Bentley, CJLM Meijer… - Vaccine, 2008 - Elsevier
With the recent advent of cervical cancer vaccines, many questions relating to the best
overall prevention methods for cervical disease are beginning to arise. A Markov model was …

Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination …

E Suarez, JS Smith, FX Bosch, P Nieminen, CJ Chen… - Vaccine, 2008 - Elsevier
Mathematical models provide valuable insights into the public health and economic impact
of cervical cancer vaccination programmes. An in-depth economic analysis should explore …

Modeling cervical cancer prevention in developed countries

JJ Kim, M Brisson, WJ Edmunds, SJ Goldie - Vaccine, 2008 - Elsevier
Cytology-based screening has reduced cervical cancer mortality in countries able to
implement, sustain and financially support organized programs that achieve broad …

Recommendations for cervical cancer prevention in Asia Pacific

SM Garland, J Cuzick, EJ Domingo, SJ Goldie, YT Kim… - Vaccine, 2008 - Elsevier
Asia Oceania includes countries from both the Asia Pacific region and Australasia, which
cover very diverse geographical areas and populations as well as bearing 52% of the …

Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program

N Demarteau, T Breuer, B Standaert - Pharmacoeconomics, 2012 - Springer
Background: Screening and vaccination against human papillomavirus (HPV) can protect
against cervical cancer. Neither alone can provide 100% protection. Consequently it raises …

Screening, prevention and treatment of cervical cancer—a global and regional generalized cost-effectiveness analysis

GM Ginsberg, TTT Edejer, JA Lauer, C Sepulveda - Vaccine, 2009 - Elsevier
The paper calculates regional generalized cost-effectiveness estimates of screening,
prevention, treatment and combined interventions for cervical cancer. Using standardised …

Modeling optimal cervical cancer prevention strategies in Nigeria

N Demarteau, IO Morhason-Bello, B Akinwunmi… - BMC cancer, 2014 - Springer
Background This study aims to assess the most efficient combinations of vaccination and
screening coverage for the prevention of cervical cancer (CC) at different levels of …

Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a …

HCW Choi, K Leung, KKL Chan, Y Bai, M Jit, JT Wu - BMC medicine, 2023 - Springer
Background Regarding primary and secondary cervical cancer prevention, the World Health
Organization proposed the cervical cancer elimination strategy that requires countries to …

Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types

EP Armstrong - Journal of managed care pharmacy, 2010 - jmcp.org
BACKGROUND: Vaccines have demonstrated cost-effectiveness in managed care through
the prevention of disease. As new vaccines for previously untargeted conditions are …

Identifying a Single Optimal Integrated Cervical Cancer Prevention Policy in Norway: A Cost-Effectiveness Analysis

A Portnoy, K Pedersen, M Nygård… - Medical Decision …, 2022 - journals.sagepub.com
Background Interventions targeting the same disease but at different points along the
disease continuum (eg, screening and vaccination to prevent cervical cancer CC) are often …